Park City Biotech Investors
Where Accredited Investors Meet the Future of Health
PCBI is a national biotech angel network specializing in AI driven, cost-reducing healthcare innovations with a proven exit market driven by Big Pharma acquisitions.
A once-in-a-generation shift in drug development is creating extraordinary investment opportunities — and Park City Biotech Investors (PCBI) exists to connect accredited investors directly to them.
We specialize exclusively in biotech startups that use AI, computational biology, and quantum biology to dramatically reduce the $2B+ average cost of bringing a drug to market. Our curated virtual pitch model means you only see deals relevant to your interests — no wasted time, no geographic barriers.
The exit market has never been stronger. With Big Pharma R&D productivity at just 1.2%, major players are acquiring innovative startups to refill their pipelines. PCBI-backed ventures are built for exactly that outcome.
